Published:17/04/2020
Vectura is presenting some of its most recent science in five poster presentations at the virtual Respiratory Drug Delivery (RDD) 2020 conference from April 26 to June 30, 2020.
The COVID-19 pandemic has caused the cancellation of the physical event in Palm Desert, California, but organisers are committed to providing the best alternative conference experience online.
Vectura’s poster details are as follows:
Title: Development of a Cyclodextrin Based Reconstitutable Powder for Delivery via Mesh Nebulization
Authors: Gemma M Keegan, Malcolm Rothery, Harneil Gill, Sandy Munro
Title: Micronisation: Amorphous Challenges and a Solution
Authors: Matthew M. J. Green, Fergus Manford and David Thomas
Title: Development of a Stable Spray Dried Formulation of an IL-17A Humabody VH Domain
Authors: Barry Derham, David Coghlan, Amy Thomas, Malcolm Rothery, Leszek Roszczyk, Nick Childerhouse, Brian McGuinness
Title: The Use of Impeller Tip Speed as a Predictive Model for Dry Powder Inhaler Blend Scale-Up and Process Transfer between Different High Shear Mixers
Authors: Nicola. L Wilkie, Christina A. Hart
Title: The Use of Data to Guide and Inform the Development of a Novel Dry Powder Inhaler
Authors: Chris Hurlstone, Phil Swanbury (joint with Team Consulting)
Podcast with Sandy Munro, VP of Pharmaceutical Development
Sandy talks about Vectura’s involvement in the all-digital RDD 2020, the science we’re be presenting, and how we’re helping customers develop inhaled medicines. Listen here.
Get in touch
As we won’t be there in person, if you’d like to talk to us about any of these posters, please click here to arrange a virtual meeting with one of our experts. You can find out more about RDD here.